http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-20002122-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c644138f2071b48b5991a1425d8dde0a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate | 1998-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2339974b1a3479d83d94110a110e1e84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10a612a530b5768defbb167f3ddb1b7c |
| publicationDate | 2000-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CZ-20002122-A3 |
| titleOfInvention | Pharmaceutical form |
| abstract | A new dosage form for active compound labile compoundsnin an acidic environment. This dosage form is not coatednenteric layers and is suitable for oral administration. |
| priorityDate | 1998-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 167.